During the past 50 years the executive search industry has grown to become a critical global enterprise. Ian Odgers, Jennifer """Innovation: Who Needs It?"" Hosted by Robert Yates, Chief Executive Officer, EMD Millipore"
Auf dem Weltwirtschaftsforum in Davos treffen sich alljährlich führende Experten, Politiker und Journalisten, um über die In a wide-ranging discussion, Dr Marijn Dekkers, recently appointed Chair at Unilever, talks to Virginia Bottomley (Chair of the
At this 2019 investor event in the US, Alan Jope talks through the high priorities for Unilever and how the business will accelerate Marijn E. Dekkers beim Bayer-Briefmarkenclub (24.09.2011)
Unilever PLC Annual General Meeting 2017 in London | Unilever Dr. Marijn Dekkers, Vorstandsvorsitzender, Bayer AG
How Bayer Developed a Cross-Cultural Senior Team Dr. Marijn Dekkers, Chairman and CEO of Bayer AG, accepts the Corporate Social Responsibility Award at the 2014 Annual
In a recently published interview in Bloomberg Businessweek, Bayer CEO Marijn Dekkers said that his company's cancer drug isn't for poor people. Vorstandvorsitzender Marijn Dekkers Aufgenommen vor dem BayKomm
Oct. 28 (Bloomberg) -- Marijn Dekkers, chief executive officer of Bayer AG, talks about generic competition in its birth control Aufgenommen im BayKomm
BB TV: Marijn Dekkers - 'Prijs van fosfaatrechten is veel te hoog' What makes a good board? Interview with Unilever Chair Dr Marijn Dekkers | Odgers Berndtson Unternehmerforum Innovation & Standort
Big Pharma CEO: Cancer Drug Only 'for Western Patients Who Can Afford It' Dekkers Says New Bayer Drugs to Help Spur Growth in 2013 Geen grote investeringen, wel werkkapitaal
Prof. Anne Glover Dec. 8 (Bloomberg) -- Marijn Dekkers, chief executive officer of Bayer AG, talks about the impact drug pricing legislation may have April 26 (Bloomberg) -- Marijn Dekkers, chief executive officer of Bayer AG, discusses the company's first-quarter profit reported
Teil 1 von 2: Marijn Dekkers ging auf der Hauptversammlung der Bayer Ag 2015 auf die Fragen zum Thema Bienensterben und Skills for tomorrow? Interview with Unilever Chair Dr Marijn Dekkers | Odgers Berndtson Het investeringsklimaat voor melkveehouders is verre van ideaal en dit wordt nogmaals onderstreept door de problemen rond de
Bayer's Dekkers Sees Room to Compete on Blood Thinners Watch the full interview with Marijn Dekkers on the Odgers Berndtson website:
Aufgenommen im Bakomm Unilever N.V. Annual General Meeting 2018 in Rotterdam | Unilever
3 de diciembre del 2013, Londres. Financial Times (FT) organiza la "CONFERENCIA GLOBAL DE FARMACEUTICAS Y 2014 Annual Dinner Marijn Dekkers Indian scientist Dr. Yusuf Hamied's proposal to cheaply manufacture and sell life-saving AIDS medications makes him "one of the
Sources: Bayer CEO: 'We don't make medicine for poor Indians', Anti-imperialism.com Marijn Emmanuel Dekkers (born 22 September 1957 in Tilburg, Netherlands) is a Dutch-American former pharmaceutical businessman.
Key Leadership Values | Interview with Unilever Chair Dr Marijn Dekkers | Odgers Berndtson Dr. Marijn Dekkers, Bayer Bayer CEO: 'This Was the Best Lesson Ever' | Fortune
Bayer CEO Marijn Dekkers says a new cancer drug is for "western patients who can afford it" Bayer CEO Marijn Dekkers explains: Nexavar cancer drug is for Interview: Davos 2013 im Zeichen der Krise? | Journal Interview
Bayer CEO Says Focused on Organic Growth, Not M&A Dr. Marijn Dekkers Clip 3
Liquiditeitsbegroting tegen volatiele melkprijs Unilever Chairman Marijn Dekkers has stepped down with immediate effect and will be replaced by its Non-Executive Director
July 28 (Bloomberg) -- Bayer AG Chief Executive Officer Marijn Dekkers discusses the company's 41 percent increase in Marijn Dekkers Says Bayer Is `Not Desperate to Do Deals'
May 3 (Bloomberg) -- Marijn Dekkers, chief executive officer of Bayer AG, talks about the company's growth and acquisition Tag der offenen Tür bei Bayer (24.09.2011) Marijn Dekkers - Wikipedia
Ginkgo Bioworks, the organism company, today announced the appointment of Dr. Marijn Dekkers, former CEO of Bayer AG and of Thermo Fisher Scientific Inc., as Bayer AG - Hauptversammlung 2015: Antworten von Marijn Dekkers (Teil 2 von 2) Clara de la Torre introduces the Global Leader session with Dr. Marijn Dekkers and Prof. Anne Glover
Bis 2030 wird die Weltbevölkerung auf 8,4 Mrd. Menschen anwachsen. Viele davon bevorzugen das Leben in der Stadt. Dr. Marijn Dekkers Clip 2 "Melkveehouders vergelijken het fosfaatrechtenstelsel ten onrechte met het melkquotum", zegt Marijn Dekkers, sectorspecialist
Dr. Marijn Dekkers, Chairman of the Board of Management of Bayer AG Presentation during the "Global leader session" at the Deutschland 2030 – Marijn Dekkers zur Zukunft der Chemie- und Pharmaindustrie Dekker is quoted as saying Bayer did not intend the cancer drug to be sold to cancer patients in India, adding "We developed it for western patients who can
What was discussed at the Unilever N.V. Annual General Meeting The 2018 Annual General Meeting of Unilever N.V. was held on Speakers of the session: - Dr. Marijn Dekkers, Chairman of the Board of Management of Bayer AG - Prof. Anne Glover, Chief
In a recently published interview in Bloomberg Businessweek, Bayer Tools to run a company | Interview with Unilever Chair Dr Marijn Dekkers | Odgers Berndtson
Dr. Marijn Dekkers, Chairman, Bayer AG BB TV: Marijn Dekkers - 'Aflossen fosfaatrechten moet binnen 5 jaar'
Dekkers Says Bayer `Successful' Passing on Higher Costs Relections on globalisation | Interview with Unilever Chair Dr Marijn Dekkers | Odgers Berndtson
Innovationspreis der deutschen Wirtschaft – 34. Gala und Preisverleihung 21. März 2015, Gesellschaftshaus Palmengarten, Marijn Dekkers - Chairman. Marijn is Chairman of Novalis Capital Partners which he founded in 2017. He is a board member of several Novalis LifeSciences Marijn E. Dekkers bei den Bayer-Numismatikern (24.09.2011)
Former astronaut, Dr. Mae Jemison, introduces Dr. Marijn Dekkers, Chairman and CEO of Bayer AG, and present him with the Building the Unilever of the future
Interview with Dr Marijn Dekkers - Chairman of Unilever What happened when an Indian drug company offered affordable AIDS medication Bayer AG - Hauptversammlung 2015: Antworten von Marijn Dekkers (Teil 1 von 2)
Bayer's Dekkers Expects German Drug Law to Raise Costs Bloomberg's viral misquote - Columbia Journalism Review
Nils Andersen made Unilever Chairman after Marijn Dekkers steps down Oct. 27 (Bloomberg) -- Marijn Dekkers, chief executive officer of Bayer AG, discusses the company's third-quarter profit reported
Alan Jope updates investors on the Unilever strategy from a global perspective | Unilever No drugs for Indian poor: Bayer CEO Marijn Dekkers Dekkers Says Bayer `Well Aligned' With China Priorities
Die Zukunft des Standorts Deutschland ist vor allem von Innovation abhängig. Gleiches gilt für die benachbarten Niederlande. Het hebben van een liquiditeitsbegroting om het melkveebedrijf te wapenen tegen lage melkprijzen is voor de moderne
Teil 2 von 2: Marijn Dekkers ging auf der HAuptversammlung der Bayer Ag 2015 auf die Fragen zum Thema Bienensterben und Big Pharma CEO: Our Medicine is for Rich People, Not The Poors
Dr. Marijn Dekkers Clip 1 Team — Novalis LifeSciences LLC
"De prijs van opties op fosfaatrechten is veel te hoog in relatie tot de beweeglijke melkprijs", zegt Marijn Dekkers, sectorspecialist 2013 - CEO de Bayer se ríe de pobres y reivindica a pacientes "occidentales" // completa Odgers Berndtson 50th anniversary
Dr. Marijn Dekkers was the first Bayer CEO to be appointed from outside the company. During his term of office, Bayer acquired, for example, the consumer care 2014 Annual Dinner Mae Jemison
Bayer's Dekkers Sees Pressure on Material, Energy Costs Marijn Dekkers, Chairman, and Graeme Pitkethly, CFO, presented at 10am UK time 15th March. "We did not develop cancer drug Nexavar for Indians" said Bayer's CEO Marijn Dekkers, we made it for "western patients who can
Bayer's CEO Dekkers to step down - PMLiVE Marijn Dekkers, PhD | FNIH Marijn Dekkers tells Fortune's Susie Gharib his best advice.
There is a difference, says CEO Marijn Dekkers. An error has occurred. This content is reserved for Subscribers only. Subscribe now for Bayer-Angebot an Merck: Die Pharmabranche sortiert sich weiter neu - corporate
April 28 (Bloomberg) -- Marijn Dekkers, chief executive officer of Bayer AG, talks about the drug and chemical maker's outlook German life sciences company Bayer announced yesterday that Marijn Dekkers will step down as CEO at the end of 2016. Dekkers, who has been at
F1 LRN PROEFRACE spa Dr. Marijn Dekkers | Bayer Global Ginkgo Bioworks Appoints Former Bayer CEO Marijn Dekkers as
Dr. Marijn Dekkers is currently the founder and chairman of Novalis LifeSciences LLC, an investment and advisory firm for the life science industry. Bloomberg News stuffed a jarring quote from Bayer CEO Marijn Dekkers at the bottom of a piece on India bypassing patents for expensive drugs.
Prof. Anne Glover, Chief Scientific Advisor to President Barroso Presentation during the "Global leader session" at the Innovation Nov. 16 (Bloomberg) -- Bayer AG Chief Executive Officer Marijn Dekkers talks about expansion in Asia. He speaks from Shanghai
Bayer will die Sparte rezeptfreie Medikamente des US-Pharmariesen Merck & Co für 10,4 Milliarden Euro übernehmen. What was discussed at the Unilever PLC Annual General Meeting The 2017 Annual General Meeting of Unilever PLC was held